Please complete the CAPTCHA to continue
@missiontherapeutics.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Paul Wallace is listed as Chief Business Officer at Constructive Bio; Chairman, NED at Constructive Bio, based in Greater Cambridge Area, United Kingdom, United Kingdom. AeroLeads shows a work email signal at missiontherapeutics.com and a matched LinkedIn profile for Paul Wallace.
Paul Wallace previously worked as Chief Business Officer at Constructive Bio and Chairman, Non-Executive Director at Semarion. Paul Wallace holds Ph.D., Biochemistry And Molecular Biology from University Of Cambridge.
This section adds company-level context without repeating Paul Wallace's masked contact details.
AeroLeads found 1 current-domain work email signal for Paul Wallace. Compare company email patterns before reaching out.
CBO for a MRC Laboratory of Molecular Biology spin-out and Chairman/NED for a University of Cambridge, Cavendish Laboratory spin-out. Previously CBO/EVP, Head of Business Development for private and publicly-listed pharmaceutical companies. Member of executive teams that have raised >$200M and completed 5 trade sales/acquisitions. Executed out-licensing partnerships to a total value of $4.5B and that resulted in 2 drugs reaching the market, including the blockbuster Olysio®. Initial research career in UK biotechs. PhD and postdoc in biochemistry from the University of Cambridge.
Listed skills include Business Development, Out Licensing, Biotechnology, Life Sciences, and 11 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Whittlesford, Cambridge, GB
Constructive Bio is a spin-out from the MRC Laboratory of Molecular Biology. The Company's technologies allow for the synthesis and recoding of entire genomes, enabling the design and production of entirely novel and improved biomolecules with unprecedented functionalities. Investors include Ahren Innovation Capital, Amadeus Capital Partners, Fine.
Cambridge, Cambridgeshire, GB
University of Cambridge, Cavendish Laboratory spin-out that is using novel materials physics to develop micro-scale cell carriers for cell-based assays: turning adherent cells into liquid reagents; for miniaturization and cell multiplexing. 2024 winner of the SLAS Ignite Award for most innovative laboratory automation start-up in Europe. 2023 winner of the.
Cambridge, Cambs, GB
Private pharmaceutical company. Targeting deubiquitylating enzymes to treat neurodegenerative disease, rare mitochondrial diseases, fibrosis, inflammation and cancers. Raised $125M venture capital from institutional and corporate investors. Strategic partnerships with AbbVie and Pfizer.
Huddinge, SE
Publicly listed pharmaceutical company. Head of business development during period when company took two drugs from research to launch (incl. HCV protease inhibitor Olysio®; $2B in first year with partner J&J) and transitioned from an early-stage R&D company into a profitable company with commercial sales. Executed 25 partnerships, the majority with major.
Public company, listed on LSE. Vaccines and protease inhibitor drugs. Trade sale to Sanofi-Aventis.
Private company. Antibody engineering and therapeutics. Trade sale to Merck KGaA.
Private company. Recombinant antibody therapeutics.Principal inventor of two humanised antibodies in late-stage clinical development for cancer indications: farletuzumab (phase III) and ontuxizumab (phase II).
Cambridge, England, GB
Biochemistry and molecular biology. Cellular targeting and processing of proteins.
Quick answers generated from the profile data available on this page.
Paul Wallace works for Constructive Bio.
Paul Wallace is listed as Chief Business Officer at Constructive Bio; Chairman, NED at Constructive Bio.
AeroLeads has found 1 work email signal at @missiontherapeutics.com for Paul Wallace at Constructive Bio.
Paul Wallace is based in Greater Cambridge Area, United Kingdom, United Kingdom while working with Constructive Bio.
Paul Wallace has worked for Constructive Bio, Semarion, Life Science Companies, Mission Therapeutics, and Medivir Ab.
You can use AeroLeads to view verified contact signals for Paul Wallace at Constructive Bio, including work email, phone, and LinkedIn data when available.
Paul Wallace holds Ph.D., Biochemistry And Molecular Biology from University Of Cambridge.
Paul Wallace is listed with skills including Business Development, Out Licensing, Biotechnology, Life Sciences, Pharmaceutical Industry, Corporate Development, Strategic Partnerships, and Executive Team.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts